Alessandro M. Vannucchi

Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis

Elisa Rumi, Daniela Pietra, Cristiana Pascutto et al. · Blood · 2014 · 380 citations · Full text

JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis

Giovanni Barosi, Gaetano Bergamaschi, Monia Marchetti et al. · Blood · 2007 · 249 citations · Full text

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation

Vittorio Rosti, Laura Villani, Roberta Riboni et al. · Blood · 2012 · 112 citations · Full text

Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms

Elisa Rumi, Daniela Pietra, Paola Guglielmelli et al. · Blood · 2013 · 92 citations · Full text

The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia

Vittorio Rosti, Margherita Massa, Alessandro M. Vannucchi et al. · Blood Cells Molecules and Diseases · 2007 · 66 citations

Hematological Malignancy, Bone Marrow Failure, Hematology +7